Cargando…
Metastatic gastric cancer – focus on targeted therapies
Gastric cancer (GC) is currently the second leading cause of cancer death worldwide; unfortunately, most patients will present with locally advanced or metastatic disease. Despite recent progress in diagnosis, surgery, chemotherapy, and radiotherapy, prognosis remains poor. A better understanding of...
Autores principales: | Meza-Junco, Judith, Sawyer, Michael B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395896/ https://www.ncbi.nlm.nih.gov/pubmed/22807624 http://dx.doi.org/10.2147/BTT.S23917 |
Ejemplares similares
-
Critical appraisal of trastuzumab in treatment of advanced stomach cancer
por: Meza-Junco, Judith, et al.
Publicado: (2011) -
Therapeutic advances in metastatic pancreatic cancer: a focus on
targeted therapies
por: Turpin, Anthony, et al.
Publicado: (2022) -
New developments in the treatment of metastatic gastric cancer: focus on trastuzumab
por: Rose, Jeffrey S, et al.
Publicado: (2011) -
The effectivity of targeted therapy and immunotherapy in patients with advanced metastatic and non-metastatic cancer of the esophagus and esophago-gastric junction
por: Valkema, M. J., et al.
Publicado: (2022) -
Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of Infigratinib
por: Yu, James, et al.
Publicado: (2021)